Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Literacy Month fosters the love of reading
2017-09-19

Description: Literacy Month fosters the love of reading Tags: Literacy Month fosters the love of reading 

Vutivi Baloyi author of Keep Hoping with Neo Kgoroba
one of the co-authors of In Our Own Words.


Literacy Month is celebrated in September each year at the University of the Free State (UFS) with various activities that are academic and community related and aim to join different departments in collaborative efforts to carry forward an awareness of literacy and the joy of reading among learners. The UFS Sasol Library lined up a series of events to celebrate the month, one of them being the launch of two books on 14 September 2017.

Vutivi Baloyi is a UFS student who wrote a collection of poems at the age of 17 which were recently published in a book called Keep Hoping. The book was launched alongside In Our Own Words, a collection of narratives written by UFS students about university life and transitioning from township high schools to a different culture, society and community, and the challenges with which they are faced.

In their own words, they share incredible experiences
The launch was attended by learners from Christian Liphoko High School in Thaba Nchu as well as Moroka High School and others. The compilation of narratives by UFS students was done under the auspices of Prof Merridy Wilson-Strydom through the Enabling Success project in the Centre for Research in Higher Education. Prof Wilson-Strydom said the project, supported by the National Research Foundation, was a profound way of empowering students by bringing out the value of the stories of their life on campus as they saw them, with each student writing a chapter on a specific theme.

Students as change agents and community builders
The student authors spoke to their audience from the heart, sharing words of advice, especially to younger learners who are still in high school. This has sparked a desire for the beginning of collaborative programmes between the individual university students and high school learners who hail from Botshabelo and Thaba Nchu, highlighting the need for mentorship, life skills, academic improvement and an opportunity to give back. 

The event is also part of the ongoing Launch Your Own Book project that has grown in 2017 at the UFS Library under the leadership of Mr Marcus Maphile, Assistant Director: Library Marketing and Community Engagement. Literacy Month will be celebrated with more events in September such as a round-table discussion in collaboration with the Academic and Non-Fiction Authors Association of South Africa (ANSAFA) on 20 September 2017 at the library, to discuss developing authors and the role of ANSAFA. More activities will include outreach and community engagement, with a visit to Christian Liphoko High School in Thaba Nchu on 21 September 2017.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept